Skip to content
ViraxImmune™
Media
Leadership
Contact
Investor Relations
ViraxImmune™
Media
Leadership
Contact
Investor Relations
Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX
July 21 2022
View Our Press Release